DUBLIN, April 28 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that at its Annual General Meeting today, all resolutions contained in the notice of meeting were duly passed and the results of the poll are as follows:
For* Against Withheld** 1. To receive the Company's accounts together with the director's and auditor's reports 385,589,148 2,271,000 26,380 2. To approve the Remuneration Report 307,647,526 60,796,610 19,442,392 3. To elect Dr Barry Price as a Director of the Company 356,441,471 31,425,618 19,439 4. To re-appoint Deloitte LLP as Auditors of the Company 387,555,848 311,630 19,050 5. To authorize the Audit, Compliance and Risk Committee to determine the remuneration of the Auditors 387,180,598 671,746 34,184 6. To authorize the allotment of shares 332,997,412 54,868,377 20,739 7. To authorize the disapplication of pre-emption rights 387,558,665 297,124 30,739 8. To authorize market purchases 387,693,316 173,212 20,000 * These figures include discretionary votes
** A vote "withheld" is not a vote in law and is not counted in the calculation of the votes "for" or "against" a resolution.
Two copies of all resolutions passed, other than resolutions concerning
ordinary business, will shortly be submitted to the UK Listing Authority and
will be available for inspection at the UK Li
|SOURCE Shire Plc|
Copyright©2009 PR Newswire.
All rights reserved